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Abstract
Introduction: Although the formation of neutrophil (PMN) extracellular traps (NETs) has been detected during
infection and sepsis, their role in vivo is still unclear. This study was performed in order to evaluate the influence of
NETs depletion by administration of recombinant human (rh)DNase on bacterial spreading, PMN tissue infiltration
and inflammatory response in a mouse model of polymicrobial sepsis.
Methods: In a prospective controlled double-armed animal trial, polymicrobial sepsis was induced by cecal ligation
and puncture (CLP). After CLP, mice were treated with rhDNase or phosphate buffered saline, respectively. Survival,
colony forming unit (CFU) counts in the peritoneal cavity, lung, liver and blood were determined. PMN and platelet
counts, IL-6 and circulating free (cf)-DNA/NETs levels were monitored. PMN infiltration, as well as organ damage, was
analyzed histologically in the lungs and liver. Capability and capacity of PMN to form NETs were determined over time.
Results: cf-DNA/NETs were found to be significantly increased 6, 24, and 48 hours after CLP when compared to
the levels determined in sham and naïve mice. Peak levels after 24 hours were correlated to enhanced capacity of
bone marrow-derived PMN to form NETs after ex vivo stimulation with phorbol-12-myristate-13-acetate at the same
time. rhDNase treatment of mice resulted in a significant reduction of cf-DNA/NETs levels 24 hours after CLP (P <
0.001). Although overall survival was not affected by rhDNase treatment, median survival after 24 hours was
significantly lower when compared with the CLP group (P < 0.01). In mice receiving rhDNase treatment, CFU
counts in the lung (P < 0.001) and peritoneal cavity (P < 0.05), as well as serum IL-6 levels (P < 0.001), were
found to be already increased six hours after CLP. Additionally, enhanced PMN infiltration and tissue damage in the
lungs and liver were found after 24 hours. In contrast, CFU counts in mice without rhDNase treatment increased
later but more strongly 24 hours after CLP (P < 0.001). Similarly, serum IL-6 levels peaked after 24 hours (P < 0.01).
Conclusions: This study shows, for the first time, that depletion of NETs by rhDNase administration impedes the
early immune response and aggravates the pathology that follows polymicrobial sepsis in vivo.
Introduction
Peritonitis and sepsis are frequent complications of criti-
cally ill patients after trauma or undergoing abdominal
surgery [1-3]. Peritonitis and sepsis, frequently related to
a polymicrobial infection with extracellular microorgan-
isms from the intestinal flora, continue to cause high
morbidity and mortality [1,4-6].
Neutrophils (PMN) represent the first line of innate
immune defense against extracellular microorganisms
[3,7-9]. Equipped with a full arsenal of antimicrobial pro-
teins at their disposal, PMN have a well described role in
phagocytic uptake and intracellular killing [10,11].
Besides their ability to eliminate microorganisms by pha-
gocytosis, it has recently been shown that activation of
PMN causes the formation of neutrophil extracellular
traps (NETs) [12-15]. This novel mechanism, for the first
time described by Brinkmann et al., consists of the
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release of web-like structures of DNA and proteins that
bind, disarm and kill pathogens extracellularly [12].
NETs have been consistently shown to entrap and kill
gram-negative and gram-positive bacteria, as well as
fungi [11-14,16]. Moreover, the confinement of patho-
gens to a local site of infection might be an important
function of NETs [16]. Nevertheless, it has been sug-
gested that the antibacterial mechanism of NETs forma-
tion occurs at the expense of injury to the host [17].
Exposure of NETs-associated proteases and other granu-
lar proteins to the extracellular environment has been
shown to damage endothelial cells in vitro [17-19]. In
models of lipopolysaccharide (LPS) induced endotoxe-
mia, NETs have been identified in the microcirculation
of the liver in the sinusoids resulting in an impaired per-
fusion and increased tissue damage measured by levels of
alanine aminotransferase (ALT) [17].
The latter observations leave NETs as a potentially
double-edged sword. On the one hand, NETs represent
an important mechanism of bacterial killing and prevent-
ing the spread of pathogens from the initial site of infec-
tion. On the other hand, NET formation may have
deleterious effects on the host due to the release of high
levels of potentially noxious proteins like proteases indu-
cing damage to the adjacent tissue [11].
Although NETs have been found to be abundant at
sites of infection and observed in the circulation in infec-
tion and sepsis [12,20-22], the pathophysiogical relevance
of NETs for in vivo conditions is still under debate. DNA
is the main structural component and scaffold of NETs
[12]. It has been shown that brief treatment of NETs
with DNase abolishes microbial killing in vitro [12]. Of
interest, bacterial trapping of Escherichia coli by activated
PMN was reduced by prior exposure to DNase in vivo
[17]. Recombinant human (rh)DNase catalyses the hydro-
lysis of extracellular DNA. Application of rhDNase has
been shown to be safe and well tolerated in the treatment
of patients with systemic lupus erythematosus and cystic
fibrosis. Thus, administration of rhDNase offers the pos-
sibility to investigate the pathophysiological role of NETs
for polymicrobial peritonitis and sepsis in vivo, which has
not been investigated so far. The aim of this study was to
evaluate the effects of the administration of rhDNase on
the inflammatory response and bacterial spreading in a
murine model of polymicrobial peritonitis and sepsis
caused by cecal ligation and puncture (CLP).
Materials and methods
Ethics statement
All animal procedures were carried out under local and
national ethical guidelines and were approved by the
regional ethical committee, Regional Office for Nature,
Environment and Consumer Protection Nordrhein-
Westfalen, Germany, with the ethical approval ID
87-51.04.2010.A112.
Animals
Wild-type C57BL/6 mice, 7 to 11-week-old females
weighing 18 to 22 grams, (animal facility of the Heinrich-
Heine-University Duesseldorf (Tierversuchsanlage, TVA,
Germany) were used for the experiments. All mice (n =
453) were housed under specific pathogen-free condi-
tions and had free access to standard rodent food and
water ad libitum.
Cecal ligation and puncture (CLP)
Polymicrobial sepsis was induced by CLP as previously
described [23]. Briefly, animals were anesthetized with an
intraperitoneal (i.p.) injection of a mixture of 10 mg/kg
xylazine and 100 mg/kg ketamine hydrochloride. The
abdomen was gently shaved and cleaned with betadine
and alcohol swabs. A 1 cm midline skin incision was
made and fascia as well as the peritoneum was opened.
The cecum was then delivered to a sterile operative field
on the abdominal surface. A 4-0 silk suture was used to
ligate approximately 50% of the cecum at its proximal
aspect without occlusion of the intestinal lumen. A 21-
gauge needle was used to puncture the cecum twice, and
a small amount of cecum content was extruded. The
cecum was then replaced into the abdominal cavity, and
the incision was closed with two layers. Sham mice were
treated identically except for the ligation and puncture of
the gut. All mice were resuscitated by an i.p. injection of
0.5 ml sterile saline. Under these conditions, all CLP
mice showed signs of severe illness within 24 hours after
induction of sepsis.
Experimental design
Mice were classified into four groups: 1) sham (n = 65);
2) sham + rhDNase (n = 20); 3) CLP (n = 207); 4) CLP +
rhDNase (n = 126). In addition, naive mice (n = 35) served
as controls. The i.p. application of rhDNase in mice was
first described by Macanovic et al. who indicated that
rhDNase concentrations between 0.1 and 1 µg/ml were
necessary to produce detectable nuclease activity in serum
[24]. Animals were treated with either 5 mg/kg rhDNase
(Pulmozyme, Roche, Grenzach-Wyhlen, Germany) or
100 µl PBS containing 2 mM Ca2+ at 1 hour, 4 hour,
7 hour, 10 hour, 21 hour, 24 hour, and 27 hour after CLP.
Sham-operated mice without cecum perforation received
the same treatment. The survival rate was monitored until
day six. At 6 hours, 24 hours and 48 hours after surgery
the blood of anesthetized mice was collected by cardiac
puncture, after which the animals were sacrificed. The
peritoneal cavity was then opened and lavaged under asep-
tic conditions with 2.5-ml aliquot of cold PBS. Part
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(100 µl) of the lavage was used for bacteria cultures. Then
the peritoneal lavage fluids were centrifuged separately
and the supernatant was stored at -20°C for subsequent
measurement of cf-DNA and DNase concentration.
Isolation of mouse PMN from bone marrow
Bone marrow-derived PMN were isolated as described
before [25]. Briefly, the bone marrow was flushed out of
the tibia and the femur using RPMI 1640 containing
2 mM glutamine supplemented with 100 U/ml penicil-
lin, 100 µg/ml streptomycin and 10 % FCS (full med-
ium) with a 2 ml syringe. Cells were pelleted and the
remaining erythrocytes were lysed using red blood cell
lysis solution (0.83% ammonium chloride, 0.1 % KHCO3
and 0.004 % ethylenediaminetetraacetic acid (EDTA)).
PMN were purified by centrifugation for 30 minutes at
500 × g on a discontinuous Percoll gradient consisting
of 55% (v/v), 68% (v/v) and 78% (v/v) Percoll (Biochrom,
Berlin, Germany) in PBS. Mature PMN were recovered
from the interphase between 68% and 78% Percoll. This
procedure revealed the purity of vital isolated PMN at
90% as confirmed by light microscopy with Diff-Quick
(Medion, Dudingen, Switzerland) staining.
Stimulation of PMN and NETs release
Freshly isolated PMN from bone marrow were resus-
pended in RPMI full medium to a final concentration of
2 × 106/ml. Cells were further stimulated with different
concentrations of phorbol-12-myristate-13-acetate
(PMA, range 0 to 100 nM) for three hours at 37°C in a
humidified atmosphere containing 5% CO2. NETs
released in the supernatant were quantified as described
below. In addition, supernatants of stimulated PMN iso-
lated from naive mice were diluted (1:5) and further
incubated with 0, 0.02, 0.2, 2.0 and 10 µg/ml of rhDNase
(Pulmozyme) for 30 minutes at 37°C before cf-DNA/
NETs quantification.
Quantification of cell free DNA
To quantify levels of circulating free (cf)-DNA/NETs in
the different groups, the Quant-iT Pico Green dsDNA
assay was used according to the manufacturer’s instruc-
tions (Invitrogen GmbH, Darmstadt, Germany). In addi-
tion, free DNA released by freshly isolated PMN after
PMA stimulation was determined in the culture superna-
tant by the same method. The fluorescence intensity
reflects the amount of DNA and was measured at excita-
tion and emission wavelengths of 485 nm and 530 nm,
respectively, in a microplate reader (Victor3, PerkinEl-
mer, Waltham, MA, USA). A standard calibration curve
by means of defined calf thymus DNA (Sigma, St. Louis,
MO, USA) amounts ranging from 0 to 2 µg/ml was used
in all analyses.
Quantification of desoxyribonuclease (DNase) and
interleukin (IL)-6 by ELISA
Desoxyribonuclease (DNase) levels in serum and perito-
neal lavage samples were measured by using ORG 590
DNase Activity Immunometric Enzyme Immunoassay for
the Quantitative Determination of DNase Activity
(ORGENTEC, Mainz, Germany) according to the manu-
facturer’s instructions. Additionally, the concentration of
DNase in mice sera was quantified using known concen-
trations of the standard provided with rhDNase1 (0.75 up
to 12.5 ng/ml). IL-6 levels in the sera were determined
using a commercially available IL-6 ELISA kit according
to the manufacturer´s instructions (R&D Systems, Abing-
don, UK). Concentrations were calculated from the stan-
dard curve constructed with recombinant murine IL-6.
The lower detection limit was 16 pg/ml IL-6.
Histology and staining procedures
Leukocyte infiltration was quantified in liver and lung
sections. In order to harvest lungs and livers, mice were
sacrificed 6 hours, 24 hours, and 48 hours after CLP.
Tissue samples were fixed in 4% formaldehyde and
embedded in paraffin according to standard procedures.
Sections (3 µm) were stained with H & E for pathological
examination. In addition, chloracetatesterase staining was
performed for specific detection and quantification of tis-
sue infiltration by PMN. PMN were counted in a blinded
and standardized fashion by light microscopy (Axiovert
40, Zeiss, Goettingen, Germany). Briefly, a micrometer
ocular (x10) was used to count PMN in 20 different
visual fields of each section. The histologic grading of
liver injury was based on the following parameters: infil-
tration of inflammatory cells, necrosis, steatosis and bal-
looning degeneration. For the scoring of lung damage,
infiltration of inflammatory cells, vascular congestion and
interstitial edema were evaluated. All parameters were
evaluated by the following score scale of values: 0, absent;
1, mild; 2, moderate; and 3, severe. All histopathological
evaluations were done in a blinded fashion by an inde-
pendent pathologist.
Counts of colony-forming units (CFU)
The number of colony-forming units (CFU) was deter-
mined in peripheral blood, the peritoneal cavity, as well
as lung and liver homogenates. Six hours, 24 hours, and
48 hours after CLP mice were sacrificed for lung and
liver removal. Lungs and livers were removed under
aseptic conditions and homogenized. Bacteria from the
peritoneal cavity were obtained by peritoneal lavage
under aseptic conditions with 2 ml cold PBS. A volume
of 30 µl of extracted peritoneal lavage was stored on ice.
Peripheral blood was isolated by cardiac puncture. Subse-
quently, 30 µl of blood and peritoneal lavage and extracts
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of organs were serially diluted in PBS, plated on Colum-
bia Agar plates with 5% sheep blood and incubated under
aerobic conditions with a minimum amount of vibration
at 37°C. Bacterial colonies were counted after 24 hours.
Results were specified as CFU per 1 ml.
Immunofluorescence staining of NETs
For immunofluorescence, freshly isolated PMN from the
bone marrow were seeded on poly-D-lysin coated cover-
slips, allowed to adhere, and stimulated with 50 nM PMA
for three hours at 37°C. Then PMN were incubated with
2 µg/ml and 20 µg/ml rhDNase for 30 minutes. Cells were
further fixed for 12 hours with 4% paraformaldehyde
(PFA) and blocked with 5% normal goat serum (NGS,
Dako, Hamburg, Germany), 0.3% Triton X-100 in PBS for
30 minutes. To stain NETs, samples were incubated with
a monoclonal mouse anti-myeloperoxidase antibody
(1:300) and a secondary fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse IgG antibody (1:200; both
Dako, Hamburg, Germany). After staining of DNA with
4’,6-diamidino-2-phenylindole (DAPI), specimens were
mounted in Dako fluorescent mounting medium (Dako).
Neutrophil-derived NET formation was visualized by
immunofluorescence microscopy (Axiovert 100, Zeiss).
Statistical analyses
Statistical analyses were performed using GraphPad Prism
5.0 (GraphPad Software, San Diega, CA, USA). Data are
presented as mean ± standard error of the mean (SEM).
Data obtained from multiple groups were tested using
one-way analysis of variance (ANOVA) followed by New-
man-Keuls post-test. Data on the bacterial load are pre-
sented as scatter plots including the median and were
tested using the nonparametric Mann-Whitney U test.
Survival data are presented as Kaplan-Meier plots. Times
of survival were compared by use of the Gehan-Wilcoxon
rank sum test; prevalences of mortality were compared
using Fisher’s exact test. Data were considered to be statis-
tically significant at P < 0.05.
Results
Increased NETs release and DNase concentration after
CLP
Levels of cf-DNA/NETs and DNase were determined in
the serum of mice at 6 hours, 24 hours and 48 hours
after CLP or sham operation (Figure 1A,B). At all time
points cf-DNA/NETs values were significantly increased
in the CLP group compared to the sham and naive
groups, with a maximum at 24 hours after CLP (P <
0.001; Figure 1A). Likewise, the levels of DNase in the
CLP group also increased as early as 6 hours after CLP
and remained elevated throughout the entire period com-
pared to the naive and sham groups (Figure 1B). In
contrast to cf-DNA/NETs levels, DNase did not decline
48 hours after sepsis induction.
Continuous capability and capacity of NET-release after
CLP
Since cf-DNA/NETs serum levels declined 48 hours
after CLP a regulation or even exhaustion of this
defense mechanism could be assumed. In order to verify
the capacity of PMN to form NETs during a septic dis-
ease, PMN were isolated from bone marrow 6, 24, and
48 hours after CLP or sham operation and stimulated ex
vivo with PMA. In addition, PMN from naive mice
served as controls. The induced cf-DNA/NETs release
was finally determined in the supernatant. PMN were
able to form NETs throughout the entire period after
CLP (Figure 1C). Neutrophil NET-producing capacity
after ex vivo PMA-stimulation was significantly
increased 24 hours after CLP in comparison to naive
and sham-operated mice. Thus, the time kinetic of the
NET-producing capacity of PMNs isolated from bone
marrow reflects the kinetic of NETs concentrations in
the blood stream after CLP.
Degradation of NETs by rhDNase in vitro
In order to prove the ability of rhDNase to degrade the
scaffold of murine NETs in vitro, supernatants of PMA-
stimulated PMN isolated from naive mice were incubated
with rhDNase and NETs were quantified by a cf-DNA/
NETs assay. As depicted in Figure 2A, NETs were disinte-
grated in a dose-dependent manner. Furthermore, qualita-
tive evidence of rhDNase-mediated NET degradation was
shown by immunofluorescence microscopy (Figure 2B).
Viable unstimulated PMN and PMN stimulated with
PMA were fixed and stained for NET components, that is,
DNA and myeloperoxidase (MPO). Exposure of fixed
NETs with rhDNase resulted in the disintegration of
NETs with loss of DNA structures. Thus, in principle
rhDNase is able to functionally destroy murine NETs
derived by activated PMN in vitro.
Degradation of NETs by rhDNase treatment in vivo
To investigate the effects of rhDNase treatment on NET
activity in vivo, serum values of cf-DNA/NETs and
DNase were determined 6, 24 and 48 hours after CLP
(Figure 3). As expected, i.p. injection of rhDNase was
associated with high DNase values in serum (Figure 3A).
DNase values declined again 24 hours after the last
rhDNase injection. However, even 48 hours after CLP,
DNase serum concentrations were still elevated by
almost 10,000 ng/ml. Most importantly, as a conse-
quence of rhDNase treatment, the peak cf-DNA/NETs
values in serum 24 hours after CLP was completely
abolished (P < 0.001; Figure 3B). Thus, it has been
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shown that degradation of NETs by rhDNase is also
possible in vivo.
The interaction of activated platelets with PMN has
been regarded as an important NET-inducing mechan-
ism in sepsis [15]. Therefore, neutrophil and platelet
counts in peripheral blood samples after CLP have been
determined (Figure 3C, D). Circulating PMN were not
affected in the early phase of sepsis in terms of absolute
numbers by rhDNase treatment during sepsis (Figure
3C). At 48 hours after CLP the neutrophil number was
elevated significantly in comparison to the number
determined after 24 hours. Interestingly, in parallel to
decreased NETs 24 hours after sepsis induction in the
rhDNase-treated CLP group, significantly higher
amounts of platelets were found in the circulation of
CLP mice treated with rhDNase at this time point (P <
0.001). In addition, the reduced NET production in vivo
after 48 hours was accompanied by a platelet drop in
the circulation (Figure 3D). Since platelets have been
shown to be an important initiating factor for NET for-
mation, the reduced platelet counts in septic mice after
48 hours might explain the reduced NET formation in
vivo later during sepsis.
Influence of NETs depletion on survival after CLP
For the purpose of further elucidating the relevance of
NETs formation on the host-defense in polymicrobial sep-
sis, the influence of rhDNase treatment on survival after
CLP or sham operation was analyzed. Interestingly, med-
ian survival after CLP of mice treated with rhDNase was
shorter than in CLP mice (CLP + DNase: 24 hours; CLP:
48 hours), although there was no significant difference in
overall survival between the two groups. However, mortal-
ity prevalence 24 hours after CLP was higher in mice trea-
ted with rhDNase than in CLP mice (P = 0.008, Fisher’s
exact test). Survival of sham mice receiving or not receiv-
ing rhDNAse did not show any differences (P = 0.08;
Gehan-modified Wilcoxon rank sum test, Figure 4).
Figure 1 Increased cf-DNA/NETs release and DNase concentration in peripheral blood as well as continuous capability and capacity of
NETs release by PMN after CLP. cf-DNA/NETs (A) and DNase (B) levels in serum of mice were determined 6, 24, and 48 hours after CLP or
sham operation, that is laparotomy without cecum perforation. Naive mice served as controls. (C) Additionally, cf-DNA/NETs were quantified in
the supernatants of freshly isolated PMN from naive, sham and CLP mice, respectively, and further stimulation with 0, 30, 50, and 100 nM PMA
for three hours PMA **P < 0.01, ***P < 0.001 versus adjacent time point within one group; #P < 0.05, ##P < 0.01, ###P < 0.001 versus sham; $P
< 0.05, $$$P < 0.001 CLP versus naïve. Cf, circulating freely; CLP, cecal ligation and puncture; DNase, desoxyribonuclease; n.d.: not detected; PMA,
phorbol-12-myristate-13-acetate; PMN, neutrophils.
Meng et al. Critical Care 2012, 16:R137
http://ccforum.com/content/16/4/R137
Page 5 of 13
Figure 2 Degradation of NETs by rhDNase in vitro. (A) PMN were isolated from bone marrow of naive mice and stimulated with 50 nM PMA.
Supernatants were incubated with 0, 0.02, 0.2, 2.0 and 20.0 µg/ml rhDNase. An rhDNase concentration of 2 µg/ml resolves 140 µg/ml of NETs
completely. n.d. = not detected. *P < 0.05, ***P < 0.001. (B) Immunofluorescence staining of NETs. The image of unstimulated PMN shows the
nuclear localization of DNA (blue fluorescence) and the granular pattern of MPO (green fluorescence; top left). After stimulation morphological
changes during NETs formation could be determined with loss of nuclear lobules and granular integrity of MPO (bottom left). Exposure of fixed
NETs with 2 µg/ml (top right) and 20 µg/ml (bottom right) rhDNase resulted in the disintegration of NETs with loss of DNA structures. CLP, cecal
ligation and puncture; DNase, desoxyribonuclease; MPO, myeloperoxidase; NETs, neutrophil extracellular traps; PMN, neutrophils; rh, recombinant
human.
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Enhanced bacterial dissemination without NETs
To evaluate the effects of NETs activity on bacterial
spreading during sepsis the number of CFU was deter-
mined in peripheral blood, the peritoneal cavity, lung,
and liver 6, 24, and 48 hours after CLP (Figure 5). Naive
or sham operated mice served as controls without any
CFU counts (data not shown). As shown in Figure 5,
already six hours after CLP, CFU counts were signifi-
cantly enhanced in the peritoneal cavity (P < 0.05) and
the lung (P < 0.001) of mice with rhDNase treatment.
Interestingly, 24 hours after CLP a rebound of CFU
counts in peripheral blood was visible with an increase
in mice without rhDNase treatment (P < 0.05).
Enhanced systemic inflammation without NETs
Depletion of NETs activity may have an influence on the
inflammatory response to infection. Therefore, serum
levels of IL-6 were measured 6, 24, and 48 hours after
CLP (Figure 6). DNase administration resulted in signifi-
cantly increased IL-6 levels compared to the CLP group
six hours after CLP. In contrast, IL-6 levels in the CLP
mice were found to increase later with a maximum after
24 hours (P < 0.01). At this time, IL-6 levels were sig-
nificantly decreased in mice receiving rhDNase treat-
ment in comparison with the CLP group (P < 0.001,
Figure 6).
Enhanced neutrophil recruitment into affected organs
without NETs
In order to analyze the effect of rhDNase treatment on
neutrophil migration into sepsis-affected organs histolo-
gical staining of lung and liver samples was performed.
There were no differences between sham animals with or
without rhDNase application (data not shown). As shown
in Figure 7, disintegration of NETs by rhDNase treatment
did not influence the neutrophil counts in the lung and
the liver early after CLP (six hours). However, 24 hours
after CLP, rhDNase treatment strongly increased the
migration of PMN in the lung and liver compared to the
CLP group. Forty-eight hours after CLP neutrophil
counts decreased again in both groups. Representative
tissue sections are depicted in Figure 7C and 7D, which
show enhanced neutrophil counts as a consequence of
rhDNase treatment 24 hours after CLP in the liver and
Figure 3 Influence of rhDNase treatment on NETs activity, neutrophil and platelet counts. cf-DNA/NETs (A) and DNase (B) levels as well
as neutrophil (C) and platelet (D) counts in serum of mice at 6 (n = 5), 24 (n = 7), and 48 (n = 7) hours treated with either 5 mg/kg rhDNase or
PBS 1, 4, 7, 10, 21, 24, and 27 hours after CLP. *P < 0.05, **P < 0.01, ***P < 0.001 versus adjacent time point within one group; ###P < 0.001
versus CLP without rhDNase. CLP, cecal ligation and puncture; DNase, desoxyribonuclease; NETs, neutrophil extracellular traps; PBS, phosphate-
buffered saline; rh, recombinant human
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lung compared to the group treated with PBS only (CLP).
The enhanced infiltration of PMN into the lung and liver
was also associated with additional histological aspects of
organ injury, for example, steatosis and ballooning
degeneration in the liver or interstitial edema in the lung,
as shown in the representative histological sections
24 hours after CLP (Figure 8). A scoring of this histologi-
cal damage shows more intense organ injury of the
Figure 4 Influence of NETs depletion on survival after CLP. Survival curve after CLP of mice treated with rhDNase. Mice were injected
intraperitoneally with either rhDNase (CLP + rhDNase, n = 20) or PBS (CLP, n = 20) 1, 4, 7, 10, 21, 24 and 27 hours after CLP and were
monitored for 6 days or until death. Sham (laparotomy without CLP) groups with (n = 10) and without rhDNase (n = 6) treatment served as
further controls. Mortality prevalence of mice treated with rhDNase was lower than in mice treated with PBS 24 hours after CLP (P < 0.01,
Fisher’s exact test).CLP, cecal ligation and puncture; DNase, desoxyribonuclease; NETs, neutrophil extracellular traps; PBS, phosphate-buffered
saline; rh, recombinant human
Figure 5 Enhanced bacterial dissemination without NETs activity. Mice were treated with rhDNase (CLP + rhDNase; n = 44) or PBS (CLP; n
= 44), respectively. Bacterial colony forming units (CFU) were recovered 6 hours (n = 8/8 in both groups), 24 hours (n = 7/14 and n = 10/14),
and 48 hours (n = 9/22 and n = 11/22) after CLP from the peritoneal cavity, peripheral blood, lung, and liver. Data from two independent
experiments are depicted. **P < 0.01, ***P < 0.001 versus adjacent time point; #P < 0.05, ###P < 0.001 versus CLP. CLP, cecal ligation and
puncture; DNase, desoxyribonuclease; NETs, neutrophil extracellular traps; PBS, phosphate-buffered saline; rh, recombinant human.
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liver 24 hours after CLP with additional rhDNase treat-
ment in comparison to the CLP group treated with PBS
only (CLP: 1.6 ± 0.6 versus CLP+rhDNase: 2.2 ± 0.3;
mean ± standard deviation, n = 6). Correspondingly, lung
damage was more pronounced in mice receiving DNase
treatment after CLP (CLP: 1.3 ± 0.6 versus CLP
+rhDNase: 2.2 ± 0.5).
Discussion
This animal study shows that application of rhDNase leads
to a profound and sustainable reduction of NETs-
mediated bactericidal activity in vivo. More importantly,
we could show that administration of rhDNase in a mur-
ine model of polymicrobial sepsis results in an advanced
sepsis progression with temporarily increased mortality
prevalence, enhanced bacterial dissemination as well as
elevated neutrophil counts in sepsis-related organs, more
severe organ injury, and higher levels of IL-6 in the circu-
lation. Our data underline the important role of NETs as
an accurate antibacterial mechanism in the early phase of
infection in polymicrobial sepsis in vivo.
After an infection, PMN are the body’s first line of
defense and kill bacteria by phagocytosis or by the produc-
tion of NETs. In a recent sepsis model, more bacteria have
been found in NETs than were phagocytized by PMN or
macrophages in vivo [17]. The authors concluded that
snaring bacteria in NETs might be more effective than
phagocytosis particularly under flow conditions. In the ser-
ious sepsis model presented here, the highest release of
NETs was detectable within the first 24 hours after CLP.
Ex vivo ability of PMN to release NETs was present over
Figure 6 Enhanced IL-6 levels without NETs activity. IL-6 levels in
the serum of mice 6 (n = 5), 24 (n = 7), and 48 (n = 7) hours after CLP
treated with either 5 mg/kg rhDNase (CLP + rhDNase) or 100 µl PBS
(CLP) 1, 4, 7, 10, 21, 24, and 27 hours after CLP. **P < 0.01, ***P <
0.001 versus adjacent time point; ###P < 0.001 versus CLP. CLP, cecal
ligation and puncture; DNase, desoxyribonuclease; IL-6, interleukin-6;
NETs, neutrophil extracellular traps; PBS, phosphate-buffered saline; rh,
recombinant human.
Figure 7 Enhanced neutrophil recruitment into the lung and liver after rhDNase treatment. (A, B) Neutrophil counts in the lung and liver
of mice 6 (n = 5), 24 (n = 7), and 48 (n = 7) hours after CLP treated with either 5 mg/kg rhDNase (CLP + rhDNase) or 100 µl PBS (CLP) 1, 4, 7,
10, 21, 24, and 27 hours after CLP. **P < 0.01, ***P < 0.001 versus adjacent time point; #P < 0.05; ###P < 0.001 versus CLP. Chloracetatesterase
staining of paraffin sections from the lung and liver of mice 24 hours after CLP treated with either 5 mg/kg rhDNase (CLP + rhDNase) or 100 µl
PBS (CLP). Representative sections of the liver (C) and lung (D) are depicted. Scale bar indicated 100 μm. CLP, cecal ligation and puncture;
DNase, desoxyribonuclease; NETs, neutrophil extracellular traps; PBS, phosphate-buffered saline; rh, recombinant human.
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the entire observation period demonstrating that during
sepsis there is no loss of PMN-mediated NET production.
Interestingly, peak levels of induced NET release in PMN
could be observed 24 hours after CLP showing good cor-
relation with the highest cf-DNA values measured in vivo
at this time. This suggests a possible priming of the NET-
formation in the acute phase of sepsis. However, the above
mentioned observations have some limitations since we
studied PMN isolated from the bone marrow which might
be functionally different from the circulating populations.
The detailed signaling mechanisms leading to the shift
from phagocytosis to NET formation during sepsis are
poorly understood. Several factors have been described as
being involved in the induction of PMN to form NETs.
Observations in PMN of chronic granulomatous disease
(CGD) patients, which exhibit severe defects in NADPH
oxidase and fail to produce reactive oxygen species (ROS),
revealed that ROS might contribute to the formation of
NETs [26]. Furthermore, beside singlet oxygen, the Raf-
MEK-ERK pathway, which is activated in many cells
during sepsis, has been shown to be involved in NETs for-
mation by promoting PMN activation [26,27].
There is a growing body of evidence that the interaction
of PMN and activated platelets is largely involved in sepsis
and that activated platelets can mediate PMN to rapidly
make NETs in vivo [11,17]. It is well established that
platelets, which are primarily involved in homeostasis, are
decreased in sepsis. Thrombocytopenia is associated with
severity and mortality during sepsis [28]. Clark et al.
recently showed in a sepsis model in vivo that NETs
formation induced by activated platelets was particularly
evident in the liver sinusoids and the capillaries of the
lung. Platelets become activated by LPS through the Toll-
like receptor (TLR)-4 receptor and bind to PMN, thus
triggering NET formation within a few minutes [17]. The
authors suggested that the platelets function as a barom-
eter in the blood, becoming activated only under very ser-
ious systemic infections to stimulate PMN to release the
proteolytic and chromatin material, thereby increasing the
capacity of the innate immune system to trap and kill cir-
culating bacteria. These findings are in line with our data,
showing an inverse correlation between NETs levels and
platelets 24 hours after CLP. In mice treated with
rhDNase, a strong decrease in cf-DNA/NETs levels could
be determined accompanied by a significant raise in the
number of platelets. It might be assumed that the dissocia-
tion of NETs by rhDNase provokes a platelet mobilization
from the bone marrow to compensate reduced NET
amounts. Thus, thrombocytopenia during sepsis might
represent a sequel of an adherence of activated platelets to
PMN during NET-formation. However, 48 hours after
CLP the correlation between NETs amount and platelet
Figure 8 Histology of liver and lung damage 24 hours after CLP with and without rhDNase treatment. (A) Histology of lung obtained
from sham mice. (B) Representative CLP-induced lung damage. (C) Representative lung of CLP mice treated with rhDNase (CLP + rhDNase). (D)
Histology of liver obtained from sham mice. (E) Representative CLP-induced liver damage. (F) Representative liver of CLP mice treated with
rhDNase (CLP + rhDNase). Sham and CLP mice were sacrificed 24 hours after surgery. Original magnification, ×10. CLP, cecal ligation and
puncture; DNase, desoxyribonuclease; rh, recombinant human.
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counts was completely different with both decreasing dra-
matically over a period of 24 hours. Because we found
PMN to be able to release NETs after ex vivo stimulation
with PMA at this time, one might speculate that 48 hours
after CLP, mice fail to produce enough NETs for disease
control due to a lack of activated platelets.
In our model, levels of cf-DNA, as part of the NETs,
were significantly reduced by continuous rhDNase appli-
cation. Although overall survival after CLP was not
affected by rhDNase treatment, mortality prevalence was
significantly lower 24 hours after CLP and median survi-
val was reduced in mice treated with rhDNase. Thus, it
appears that NETs production by activated PMN is a
crucial antibacterial effector in the early phase of infec-
tion in vivo. This assumption is further supported by
our data obtained six hours after CLP showing that, in
contrast to the control group, rhDNase-treated mice dis-
played a rapid and considerable increase of CFU counts
at the site of infection as well as in the lung. Neverthe-
less, 24 hours after CLP a rebound was detectable with
fewer CFU counts in the blood in mice treated with
rhDNase. It seems, therefore, that provoked reduction of
the amount of NETs early after sepsis induction inevita-
bly leads to a disturbed eradication of bacteria at the
infection site allowing bacteria to spread in the system.
However, in a preliminary experiment rhDNase treat-
ment up to 72 hours after CLP did not influence the
survival of the mice, arguing again for the superior role
of NETs only during the early phase after infection. It is
possible that the missing effect of rhDNase on the over-
all survival rate is explained by our experimental proto-
col. Here, we used a comparable serious bacterial load
and an overall survival rate of 20 % after six days on
average. In addition, the formation of the NETs was
abolished by rhDNase treatment only within the first 48
hours after CLP.
Therapeutic administration of rhDNase is currently
used to treat chronic pulmonary disease in cystic fibrosis
and systemic lupus erythematosus [29]. There is evidence
that treatment with rhDNase is associated with an
improvement in lung function [12]. However, the influ-
ence of rhDNase treatment on bacterial colonization of
the airways in cystic fibrosis has been investigated with
conflicting results. While Frederisken et al. found
rhDNase application to be beneficial to cystic fibrosis
patients, in another more recent study the authors did
not find any long-term effects of rhDNase on the pul-
monary bacterial airway colonization [30,31]. However,
the most profound difference was found for Staphylococ-
cus aureus and gram negative bacteria. Recently, the abil-
ity of important gram positive bacterial pathogens such
as Streptococcus pneumoniae and also certain S. aureus
strains to resist NET-dependent killing has been linked
to their ability to secrete nucleases, which might also
explain such a change in bacterial findings after rhDNase
therapy. However, in this study we did not further differ-
entiate bacterial infiltration in detail. Although macro-
scopic examination of CFU plates did not reveal any
significant differences (data not shown), rhDNase therapy
in sepsis potentially might lead to a shift of bacterial
colonization to bacterial strains with a certain resistance
to NET-dependent killing in vivo, which could influence
the value of bacterial dissemination into organs and the
outcome. Nevertheless, this speculative assumption
should be addressed in further investigations.
Most pathogens are killed after they have been trapped
by NETs [12,16]. Pathogens entrapped in the NETs are
dispatched possibly after being exposed to a high local
concentration of antimicrobial proteins [12,32]. On the
other hand, it has recently been shown, that microorgan-
isms captured by NETs and thought to be killed remain
viable in the construct by undefined mechanisms [33].
Therefore, it has been suggested that confinement of bac-
teria to the local site of infection and thus prevention of
further spread of bacteria, is another important function
of NETs. Having shown that maximal release of NETs is
achieved within 24 hours after CLP, this confinement of
bacteria by NETs is obviously temporally restricted and
their relevance in the late phase of sepsis seems to
decline. Moreover, depending on the amount of bacteria,
the physical barrier built by NETs may break down in
time and allow bacteria to disseminate into sepsis-related
organs.
During early sepsis, PMN become activated and lodge
primarily in the capillaries of the lungs and the sinusoids
of the liver [34]. In our study, neutrophil counts were sig-
nificantly increased 24 hours after CLP in the lung and
liver of mice treated with rhDNase and more pronounced
injury has been found in these organs. IL-6, an important
proinflammatory cytokine in response to infection, is
increased after CLP in mice [35]. Indeed, in our model,
blood levels of IL-6 increased significantly, reaching max-
imal levels 24 hours after CLP. In accordance with our
previous data suggesting aggravation of infection by
rhDNase treatment, IL-6 levels were found to rise faster
in the rhDNase-treated group, and the highest cytokine
concentrations were measured after six hours. These
results indicate that the elimination of NETs exacerbates
the inflammatory process early after CLP resulting in a
shift of the inflammatory response to an earlier time
point.
Conclusions
NETs formation plays an important role in bacterial con-
trol during polymicrobial sepsis in vivo. It becomes evi-
dent that depletion of NETs modulates the immune
reaction and aggravates the pathology that follows a poly-
microbial sepsis in vivo. Strategies of NETs induction
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rather than NETs destruction might be a promising ther-
apeutic approach for septic patients in the future.
Key messages
• Application of rhDNase leads to a pronounced and
sustainable reduction of NETs-mediated bactericidal
activity in a mouse model of polymicrobial sepsis
(CLP) in vivo.
• Administration of rhDNase results in an advanced
sepsis progression with increased mortality preva-
lence and enhanced bacterial dissemination in vivo.
• Administration of rhDNase does not alter overall
survival after CLP.
• rhDNase therapy is associated with elevated neu-
trophil counts in sepsis-related organs, enhanced tis-
sue damage and higher levels of IL-6 in the
circulation early after CLP in vivo.
• Formation of NETs is an accurate antibacterial
mechanism in the early phase of infection in polymi-
crobial sepsis in vivo.
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